Preventive medicine
-
Preventive medicine · Dec 2023
Multicenter Study23-valent pneumococcal polysaccharide vaccine and the risk of renal progression in older patients with chronic kidney disease.
The 23-valent pneumococcal polysaccharide vaccine (PPSV23) ensures favorable outcomes and reduces the risk of cardiac events in patients on dialysis. However, the effect of PPSV23 vaccination on renal function remains unknown, particularly in patients with chronic kidney disease (CKD). Therefore, we investigated the association between PPSV23 efficacy and renal progression in older patients (age ≥ 75 years) with CKD. ⋯ Our findings support the protective effect of PPSV23 against renal deterioration in older patients with CKD.